q.beyond
Tracked across 2 events · 12 articles · First seen May 06, 2026 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
q.beyond, a medical device and biopharmaceutical company, has received an extension from the Nasdaq-100 Hearings Panel to regain compliance with Nasdaq-100's bid price rule by July 31, 2026. The company's stock has been trading below…
Impact: q.beyond has been granted an extension by the Nasdaq-100 Hearings Panel to regain compliance with the bid price rule, allowing it to maintain its listing on The Nasdaq-100 Stock Market until July 31, 2026. The company plans to propose a reverse stock split to its shareholders to address this issue.
Jun 01, 2026 · 6 articles
100
Nasdaq-100 granted extension q.beyondBeyond_Air Nasdaq Listing...
90
q.beyond will vote on proposalBeyond_Air Nasdaq Listing...
20
q.beyond terminated transaction Mapp BiopharmaceuticalBeyond_Air Nasdaq Listing...
NEWSDESK
Track q.beyond live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard